financetom
Business
financetom
/
Business
/
US trade panel's vote paves way for stiff tariffs on many solar imports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US trade panel's vote paves way for stiff tariffs on many solar imports
May 26, 2025 11:04 AM

(Reuters) -The U.S. International Trade Commission determined on Tuesday that domestic solar panel makers were materially harmed or threatened by a flood of cheap imports from four Southeast Asian nations, bringing the United States a step closer to imposing stiff duties on those goods.

The "yes" vote by the three-member ITC means the Commerce Department will issue orders to enforce countervailing and anti-dumping tariffs on solar products imported from Malaysia, Thailand, Cambodia and Vietnam that the agency finalized last month.

The vote resolves a year-old trade case in which American manufacturers accused Chinese companies of flooding the market with unfairly cheap goods from factories in Southeast Asia. Since that time, President Donald Trump has pursued a broad strategy to impose tariffs on imported products to protect manufacturers of U.S.-made goods.

The Commerce Department cannot impose tariffs unless the ITC finds that the domestic industry was harmed or threatened by overseas rivals receiving unfair subsidies and dumping products in the U.S. market.

The outcome of the vote was posted in a brief notice on the ITC's web site. It was not immediately clear how each commissioner voted.

The trade case was brought last year by Korea's Hanwha Qcells, Arizona-based First Solar Inc and several smaller producers seeking to protect billions of dollars in investments in U.S. solar manufacturing.

"(Tuesday's) vote leaves no doubt: these Chinese-headquartered companies have been violating trade laws by overwhelming the U.S. market with unfairly cheap, dumped and subsidized solar panels - and they continue to do so from third-party markets around the world, undermining U.S. industrial strategy and stunting new investment," Tim Brightbill, the lead attorney for the petitioning group, the American Alliance for Solar Manufacturing Trade Committee, said in a statement. 

"This cannot stand. Our growing American industry deserves - and now will have - the chance to compete fairly," Brightbill said.

The vast majority of panels installed in the United States are imported from Asia. 

In 2022, former President Joe Biden's signature climate change law, the Inflation Reduction Act, created a tax credit for clean energy manufacturing, and more than 100 solar factories have been announced or expanded since then, according to the American Clean Power Association trade group.

A top U.S. solar trade group, the Solar Energy Industries Association, said new tariffs would actually harm domestic producers by increasing costs for panel buyers.    

"(Tuesday's) decision by the U.S. International Trade Commission is concerning for American solar manufacturers and the broader U.S. solar industry," SEIA President Abigail Ross Hopper said in a statement. "The USITC's final affirmative injury determination adds an additional layer of tariffs that will raise costs for the solar products American companies need to build projects and grow domestic manufacturing."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA staff flags safety concerns from J&J, Bristol's CAR-T therapies
US FDA staff flags safety concerns from J&J, Bristol's CAR-T therapies
Mar 13, 2024
March 13 (Reuters) - The U.S. Food and Drug Administration's staff reviewers on Wednesday raised safety concerns over the use of Johnson & Johnson's ( JNJ ) and Bristol Myers Squibb's ( BMY ) cancer therapies as earlier treatments for blood cancer patients. Staff reviewers said that the pattern of early deaths observed in patients treated with both the therapies...
EXPLAINER-What is bitcoin's 'halving', and does it matter?
EXPLAINER-What is bitcoin's 'halving', and does it matter?
Mar 13, 2024
LONDON, March 13 (Reuters) - As bitcoin's price reaches new heights, attention is turning to its upcoming halving and whether it is playing a role in its ascent. Depending on where you sit, the halving is a vital event that will burnish bitcoin's value as an increasingly scarce commodity, or nothing more than a technical change talked up by speculators...
Why Is Broadband Provider WideOpenWest Stock Trading Lower Wednesday?
Why Is Broadband Provider WideOpenWest Stock Trading Lower Wednesday?
Mar 13, 2024
WideOpenWest, Inc ( WOW ) reported a fourth-quarter revenue decline of 6% year-on-year to $168.8 million, missing the consensus of $170.6 million. EPS loss of $(0.54) missed the consensus loss of $(0.01). The stock price slipped after the results. HSD Revenue totaled $108.7 million, up by 1% Y/Y. Total Subscription Revenue for the quarter was $155.5 million, down by 5% Y/Y, primarily driven...
BeiGene, Max Foundation Providing Brukinsa to Leukemia Patients in Armenia, Nepal as Part of 3-Year Partnership
BeiGene, Max Foundation Providing Brukinsa to Leukemia Patients in Armenia, Nepal as Part of 3-Year Partnership
Mar 13, 2024
09:00 AM EDT, 03/13/2024 (MT Newswires) -- BeiGene ( BGNE ) , the Max Foundation, and the charitable BeiGene Foundation said Wednesday the first doses of Brukinsa (zanubrutinib) have been provided to patients with chronic lymphocytic leukemia in Armenia and Nepal. The organizations said they expect to deliver the medication in 29 low- and middle-income countries under their three-year partnership....
Copyright 2023-2026 - www.financetom.com All Rights Reserved